ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

17,678Medicare Part D Prescriptions Filled, Including Refills

Rank: 223 out of 6645

$847K Total Retail Price of All Prescriptions

Rank: 445 out of 6645

833 Patients Receiving at Least One Drug in Part D
72%Patients 65 Years and Older
86% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

18% of this provider’s 833 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

5% of this provider’s 12,895 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
BENAZEPRIL HCL 1,169 925 10 1 21
SIMVASTATIN 1,073 814 2 1
METFORMIN HCL 823 634 3 7
OMEPRAZOLE 744 512 4 6
ATENOLOL 579 480 5 8
LEVOTHYROXINE SODIUM 529 385 6 4
AMLODIPINE BESYLATE 464 376 7 2
HYDROCODONE-ACETAMINOPHEN 444 300 S3 8 5
IBUPROFEN 397 222 9 42
GLYBURIDE 384 278 R 10 58
FUROSEMIDE 374 309 11 11
TRIAMCINOLONE ACETONIDE 332 215 12 55
TAMSULOSIN HCL 327 296 13 22
TRAMADOL HCL 311 256 14 30
CITALOPRAM HBR 286 224 15 35
ACTOS 269 204 16 71
CARVEDILOL 261 192 17 25
LISINOPRIL 250 202 18 3
ZOLPIDEM TARTRATE 231 195 19 17
METOPROLOL TARTRATE 216 166 20 13
GLYBURIDE-METFORMIN HCL 180 160 R 21 95
FAMOTIDINE 180 132 21 33
GABAPENTIN 177 92 23 18
LANTUS 171 95 24 50
DONEPEZIL HCL 154 137 25 27
HYDROCHLOROTHIAZIDE 152 91 26 9
PANTOPRAZOLE SODIUM 148 120 27 29
KLOR-CON 8 142 117 28 123
GLIPIZIDE 141 115 29 23
MECLIZINE HCL 125 117 30 122
OXYBUTYNIN CHLORIDE 123 71 31 129
BACLOFEN 116 66 32 100
PIOGLITAZONE HCL 116 92 R 32 184
LOSARTAN POTASSIUM 112 69 34 12
ALLOPURINOL 111 85 35 31
VENTOLIN HFA 111 45 35 146
FLOVENT HFA 110 70 37 293
WARFARIN SODIUM 110 89 37 16
DIOVAN 110 101 37 19
ISOSORBIDE DINITRATE 108 101 40 200
TRIAMTERENE-HYDROCHLOROTHIAZID 104 86 41 143
INSULIN SYRINGE 101 69 42 61
LORATADINE 100 48 43 250
ATORVASTATIN CALCIUM 97 54 44 10
NAMENDA 93 88 45 41
POTASSIUM CHLORIDE 93 62 45 28
ALENDRONATE SODIUM 92 89 47 14
NIFEDIPINE ER 92 71 47 82
AZITHROMYCIN 92 62 47 44
CIPROFLOXACIN HCL 90 73 50 67
ENALAPRIL MALEATE 89 62 51 75
FINASTERIDE 88 76 52 73
FLUTICASONE PROPIONATE 81 40 53 26
LOVASTATIN 79 45 54 15
METOPROLOL SUCCINATE 76 58 55 24
DIGOXIN 72 67 56 59
JANUVIA 72 62 56 38
LEVOFLOXACIN 71 58 58 83
CLONIDINE HCL 67 38 59 56
LACTULOSE 67 52 59 125
CLOPIDOGREL 65 45 61 36
VYTORIN 63 63 62 170
AMLODIPINE BESYLATE-BENAZEPRIL 60 60 63 97
AMITRIPTYLINE HCL 59 36 R 64 117
AMOX TR-POTASSIUM CLAVULANATE 59 42 64 185
RANITIDINE HCL 56 52 66 51
PHENYTOIN SODIUM EXTENDED 56 20 66 172
PREMARIN 53 22 R 68 169
NIFEDICAL XL 51 38 69 295
OLANZAPINE 50 31 70 140
PLAVIX 50 34 70 49
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 30, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.